137 related articles for article (PubMed ID: 37536510)
1. Nasal IL-13 production identifies patients with late-phase allergic responses.
Campion NJ; Villazala-Merino S; Thwaites RS; Stanek V; Killick H; Pertsinidou E; Zghaebi M; Toth J; Fröschl R; Perkmann T; Gangl K; Schneider S; Ristl R; Scott IC; Cohen ES; Molin M; Focke-Tejkl M; Regelsberger G; Hansel TT; Valenta R; Niederberger-Leppin V; Eckl-Dorna J
J Allergy Clin Immunol; 2023 Nov; 152(5):1167-1178.e12. PubMed ID: 37536510
[TBL] [Abstract][Full Text] [Related]
2. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
[TBL] [Abstract][Full Text] [Related]
3. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.
Scadding GW; Calderon MA; Bellido V; Koed GK; Nielsen NC; Lund K; Togias A; Phippard D; Turka LA; Hansel TT; Durham SR; Wurtzen PA
J Immunol Methods; 2012 Oct; 384(1-2):25-32. PubMed ID: 22759401
[TBL] [Abstract][Full Text] [Related]
4. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.
Wagenmann M; Schumacher L; Bachert C
Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297
[TBL] [Abstract][Full Text] [Related]
5. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis.
Klimek L; Dormann D; Jarman ER; Cromwell O; Riechelmann H; Reske-Kunz AB
Clin Exp Allergy; 1999 Oct; 29(10):1326-35. PubMed ID: 10520053
[TBL] [Abstract][Full Text] [Related]
6. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
[TBL] [Abstract][Full Text] [Related]
7. Pollen derived low molecular compounds enhance the human allergen specific immune response in vivo.
Gilles-Stein S; Beck I; Chaker A; Bas M; McIntyre M; Cifuentes L; Petersen A; Gutermuth J; Schmidt-Weber C; Behrendt H; Traidl-Hoffmann C
Clin Exp Allergy; 2016 Oct; 46(10):1355-65. PubMed ID: 27061126
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
9. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
[TBL] [Abstract][Full Text] [Related]
10. Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine.
Dumitru AF; Shamji M; Wagenmann M; Hindersin S; Scheckenbach K; Greve J; Klenzner T; Hess L; Nebel S; Zimmermann C; Zahner C; Schmidt-Weber CB; Chaker AM
J Allergy Clin Immunol; 2011 Jun; 127(6):1515-21.e6. PubMed ID: 21489609
[TBL] [Abstract][Full Text] [Related]
11. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation.
KleinJan A; Dijkstra MD; Boks SS; Severijnen LA; Mulder PG; Fokkens WJ
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):441-50. PubMed ID: 10069878
[TBL] [Abstract][Full Text] [Related]
12. The response to nasal allergen provocation with grass pollen is reduced in patients with chronic rhinosinusitis with nasal polyposis and grass sensitization.
Calus L; Devuyst L; Van Zele T; De Ruyck N; Derycke L; Bachert C; Gevaert P
Clin Exp Allergy; 2016 Apr; 46(4):555-63. PubMed ID: 26661927
[TBL] [Abstract][Full Text] [Related]
13. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
[TBL] [Abstract][Full Text] [Related]
14. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis.
van Hage-Hamsten M; Johansson E; Roquet A; Peterson C; Andersson M; Greiff L; Vrtala S; Valenta R; Grönneberg R
Clin Exp Allergy; 2002 Oct; 32(10):1448-53. PubMed ID: 12372124
[TBL] [Abstract][Full Text] [Related]
15. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
[TBL] [Abstract][Full Text] [Related]
16. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
[TBL] [Abstract][Full Text] [Related]
17. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
18. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033
[TBL] [Abstract][Full Text] [Related]
19. Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2-type inflammation but no evidence of remodelling.
Orban NT; Jacobson MR; Nouri-Aria KT; Durham SR; Eifan AO
Clin Exp Allergy; 2021 Feb; 51(2):329-338. PubMed ID: 33141493
[TBL] [Abstract][Full Text] [Related]
20. [Clinical symptoms and immunology inspection characteristics of nasal cavity local allergy].
Yin ZX; Zhu Y; Zhai X; Zhang JL; Liu G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1146-1151. PubMed ID: 29798346
[No Abstract] [Full Text] [Related]
[Next] [New Search]
